The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Gold nanoparticles as computerized tomography (CT) contrast agents
Abstract
Gold nanoparticles (GNPs) are emerging as one of the most promising contrast agents for computerized tomography (CT) due to their remarkable properties including high X-ray absorption coefficient, low cytotoxicity, tailored surface chemistry, excellent biocompatibility, and unique surface plasmon resonance. Moreover, GNPs with tumor cell targeting molecules can specifically show the tumor tissues, leading to an intriguing feature of molecular imaging. In this article we provide a historical perspective on the GNPs used as CT contrast agents. We summarize the CT imaging principles of GNPs, review the current status of available methodologies for their preparation and surface modification, and highlight the recent achievements in their contrast effect and toxicity. Finally, the future opportunities and challenges of GNPs used as CT contrast agents are addressed for our understanding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jacquemont, S., Curie, A., des Portes, V., Torrioli, M. G., Berry-Kravis, E., Hagerman, R. J., Ramos, F. J., Cornish, K., He, Y., Paulding, C., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001708 · Cited by 609
Nanocrystal Core High-Density Lipoproteins: A Multimodality Contrast Agent Platform
Cormode, D. P., Skajaa, T., van Schooneveld, M. M., Koole, R., Jarzyna, P., Lobatto, M. E., Calcagno, C., Barazza, A., Gordon, R. E., Zanzonico, P., et al. (2008) · Nano Letters · doi:10.1021/nl801958b · Cited by 328
The Fate and Toxicity of Raman-Active Silica-Gold Nanoparticles in Mice
Thakor, A. S., Luong, R., Paulmurugan, R., Lin, F. I., Kempen, P., Zavaleta, C., Chu, P., Massoud, T. F., Sinclair, R., & Gambhir, S. S. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001963 · Cited by 159
Templated Spherical High Density Lipoprotein Nanoparticles
Thaxton, C. S., Daniel, W. L., Giljohann, D. A., Thomas, A. D., & Mirkin, C. A. (2009) · Journal of the American Chemical Society · doi:10.1021/ja808856z · Cited by 122
Cited by
Nanomaterials for In Vivo Imaging
Smith, B. R., & Gambhir, S. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00073 · Cited by 1,075
Polymeric Nanostructures for Imaging and Therapy
Elsabahy, M., Heo, G. S., Lim, S.-M., Sun, G., & Wooley, K. L. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00135 · Cited by 508
Role of gold nanoparticles in advanced biomedical applications
Bansal, S. A., Kumar, V., Karimi, J., Singh, A. P., & Kumar, S. (2020) · Nanoscale Advances · doi:10.1039/d0na00472c · Cited by 356
Radiolabelling of nanomaterials for medical imaging and therapy
Pellico, J., Gawne, P. J., & T. M. de Rosales, R. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00384k · Cited by 304
Advanced hybrid nanomaterials for biomedical applications
Park, W., Shin, H., Choi, B., Rhim, W.-K., Na, K., & Keun Han, D. (2020) · Progress in Materials Science · doi:10.1016/j.pmatsci.2020.100686 · Cited by 299
Metadata
- Authors
- Xi, D., Dong, S., Meng, X., Lu, Q., Meng, L., & Ye, J.
- Venue
- RSC Advances
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2012
- Volume
- 2
- Issue
- 33
- Pages
- 12515
- ISSN
- 2046-2069 (ISSN-L)
- OpenAlex
- W1990194688
- Cited by
- 159
- References
- 4
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gold nanoparticles as computerized tomography (CT) contrast agents. https://app.cochat.ai/papers/10.1039/c2ra21263c
- The paper
- Xi, D., Dong, S., Meng, X., Lu, Q., Meng, L., & Ye, J. (2012). Gold nanoparticles as computerized tomography (CT) contrast agents. RSC Advances. https://doi.org/10.1039/c2ra21263c
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.